Adaptive multi-view multi-label learning for identifying disease-associated candidate miRNAs - Fig 6

(A) The expression profiles of hsa-mir-181a-2 at different tumor stages. P-value was calculated by one-way ANOVA test; (B) Kaplan-Meier survival analysis using hsa-mir-181a-2 in thyroid cancer. The patients were divided into two groups ’High’ and ’Low’ according to their expression level of hsa-mir-181a-2 against the sample mean. As observed, patients with lower expression levels were at lower risk level.